Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin Versus Trabectedin Plus Radiation in Gynecologic Soft Tissue Sarcoma
KCT0010391Phase 2Not yet recruiting
- Sponsor
- Asan Medical Center
- Start
- Apr 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in soft tissue sarcoma (STS), sponsored by Asan Medical Center. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
trabectedin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on KCT0010391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010391.